Novel PET Tracers for Prostaglandin Receptors

前列腺素受体的新型 PET 示踪剂

基本信息

  • 批准号:
    11694143
  • 负责人:
  • 金额:
    $ 7.87万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1999
  • 资助国家:
    日本
  • 起止时间:
    1999 至 2001
  • 项目状态:
    已结题

项目摘要

An artificial prostaglandin, 15R-MTC, selectively binds to a novel prostacyclin receptor, IP_2, expressed in the central nervous system. In order to analyze function of IP_2 receptor by positron emission tomography ( PET ), design and synthesis of PET tracers and specific molecular probes based on 15R-T1C were conducted. First, rapid methylation reaction using a coordinatively unsaturated palladium ( O ) complex was elaborated for the synthesis of PET tracers with ^<11>C-CH3. This reaction was successfully applied to the synthesis of ^<11>C-labeled 15fl-TIC methyl ester with a synthetic apparatus at Uppsala University PET Centre. Specific location of the IP_2 in the brain of a living rhesus monkey was then clearly visualized by PET using the tracer. Furthermore, stepwise operation for the rapid methylation was developed, which allowed for the highly reproducible synthesis of ^<11>C-15R-TIC methyl ester with total radioactivity of ca. 2.5 GBq. This protocol enables to supply efficient radioactive PET tracers applicable to the study of human brains with volumes ten-times those of monkeys. Biological function of 15R-TIC was also investigated. Thus the compound was found to prevent the apoptotic cell death of hippocampal neurons induced under high oxygen atmosphere or serum deprivation in vitro, and in vivo, reduce the volume of brain damage in a rat model of focal cerebral ischemia. Additionally, 15-deoxy-TIC, a structurally simplified analog of 15R-TIC, was designed and synthesized. The binding affinity of 15-deoxy-TIC to IP_2 receptor was more than ten-times that of 15R-TIC, and the apoptotic death of hippocampal neurons was completely prevented by the low dose of the compound. The methyl ester of 15-deoxy-TIC could pass through the BBB to reach the brain efficiently, and revealed strong activity for brain protection in the rat model of ischemia. The synthesis of ^<11>C-labeled 15-deoxy-TIC methyl ester was also accomplished by the stepwise methylation protocol.
人工合成的前列腺素15 R-MTC可与中枢神经系统表达的新型前列环素受体IP_2选择性结合。为了利用正电子发射断层扫描(PET)技术分析IP_2受体的功能,设计并合成了基于15 R-T1 C的PET示踪剂和特异性分子探针。首先,阐述了使用配位不饱和钯(O)络合物的快速甲基化反应用于合成具有^C-CH 3的PET示踪剂<11>。该反应成功地应用于<11>Uppsala大学PET中心的合成装置合成15 C-标记的15 fl-TIC甲酯。然后用PET显像技术观察到IP_2在活体恒河猴脑内的具体位置。此外,开发了用于快速甲基化的分步操作,其允许高度可重复地合成<11>总放射性为约1000的^ C-15 R-TIC甲酯。2.5 GBq。该协议能够提供有效的放射性PET示踪剂,适用于研究人类大脑的体积是猴子的十倍。并对15 R-TIC的生物学功能进行了初步研究。因此,发现该化合物在体外可防止在高氧气氛或血清剥夺下诱导的海马神经元的凋亡性细胞死亡,并且在体内可减少局灶性脑缺血大鼠模型中的脑损伤体积。此外,15-脱氧-TIC,一种结构简化的类似物的15-R-TIC,被设计和合成。15-deoxy-TIC与IP_2受体的结合亲和力是15 R-TIC的10倍以上,低剂量的15-deoxy-TIC可完全阻止海马神经元的凋亡。15-deoxy-TIC甲酯能有效地通过血脑屏障到达脑组织,对缺血性脑损伤大鼠具有较强的脑保护作用。15 <11>C标记的15-脱氧-TIC甲酯的合成也通过逐步甲基化方案完成。

项目成果

期刊论文数量(120)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Satoh,T,: "Prostaglandin J2 and Its Metabolites Promote Neurite Outgrowth Induced by Nerve Growth Factor in PC12 Cells"Biochem. Biophys. Res. 258. 50-53 (1999)
Satoh,T,:“前列腺素 J2 及其代谢物促进 PC12 细胞中神经生长因子诱导的神经突生长”Biochem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Satoh,T.: "Designed Cyclopentenone Prostaglandin Derivatives as Neurite Outgrowth-promoting Compounds for CAD Cells, a Rat Catecholaminergic Neuronal Cell Line of The Central Nervous System"Neurosci. Lett.. 291. 167-170 (2000)
Satoh, T.:“设计环戊烯酮前列腺素衍生物作为 CAD 细胞的神经突生长促进化合物,CAD 细胞是中枢神经系统的大鼠儿茶酚胺能神经元细胞系”Neurosci。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Satoh: "Neurotrophic actions of novel compounds designed from cyclopentenone prostaglandins"J. Neurochem.. 77・1. 50-62 (2001)
T. Satoh:“由环戊烯酮前列腺素设计的新型化合物的神经营养作用”J. Neurochem.77・1(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S. Fukushima: "Antitumor activity, optimum administration method and pharmacokinetics of 13,14-dihydro-15-deoxy-Δ^7-prostaglandin A, methyl ester(TEI-9826) integrated in lipid microspheres(Lipo TEI-9826)"Anticancer Drugs. 12・3. 221-234 (2001)
S. Fukushima:“整合在脂质微球(Lipo TEI-9826)中的 13,14-二氢-15-脱氧-Δ^7-前列腺素 A 甲酯(TEI-9826)的抗肿瘤活性、最佳给药方法和药代动力学”药物 12・3。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Satoh et al.: "Prostaglandin J_2 and Its Metabolites Promote Neurite Outgrowth Induced by Nerve Growth Factor in PC12 Cells."Biochem.Biophys.Res.Commun.. 258. 50-53 (1999)
T.Satoh 等人:“前列腺素 J_2 及其代谢物促进 PC12 细胞中神经生长因子诱导的神经突生长。”Biochem.Biophys.Res.Commun. 258. 50-53 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUZUKI Masaaki其他文献

TAKANO-YAMAMOTO Teruko Japanese men OSAHS patient's anatomical features
TAKANO-YAMAMOTO Teruko 日本男性 OSAHS 患者的解剖特征

SUZUKI Masaaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUZUKI Masaaki', 18)}}的其他基金

Development of PET probes of neuroprotective molecular components in oriental medicines
韩方神经保护分子成分PET探针的研制
  • 批准号:
    25242070
  • 财政年份:
    2013
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Development of three-dimensional pi-electronic compounds originated from tripyrrin subunits
源自三吡啉亚基的三维π电子化合物的开发
  • 批准号:
    24750034
  • 财政年份:
    2012
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
On epimorphisms between knot groups non-preserving meridians
论结群不守经脉间的同态
  • 批准号:
    24740035
  • 财政年份:
    2012
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development and exploration of expanded porphyrins bearing intramolecular conjugation bridges
具有分子内共轭桥的扩展卟啉的开发与探索
  • 批准号:
    22750031
  • 财政年份:
    2010
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
A Study on the faithfulness of the graded Magnus representation of the mapping class group
映射类群分级马格努斯表示的忠实度研究
  • 批准号:
    21740033
  • 财政年份:
    2009
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of Porphyrinoid Materials Aimed at Non-linear Optics and Photodynamic Therapy
用于非线性光学和光动力治疗的类卟啉材料的开发
  • 批准号:
    20850004
  • 财政年份:
    2008
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Young Scientists (Start-up)
Development of Nitrogen Isotope Separation Method using Plasma Chemical Reactions
利用等离子体化学反应开发氮同位素分离方法
  • 批准号:
    19360424
  • 财政年份:
    2007
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Relations of depositional processes on coastal and alluvial plains formation and the Late Holocene climate change
沿海和冲积平原形成的沉积过程与全新世晚期气候变化的关系
  • 批准号:
    18500784
  • 财政年份:
    2006
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Three-dimensional morphological analyses of positional dependence in patients with obstructive sleep apnea syndrome
阻塞性睡眠呼吸暂停综合征患者位置依赖的三维形态学分析
  • 批准号:
    17591802
  • 财政年份:
    2005
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Radio-Active Waste Decontamination Process by Using Atmospheric Pressure Plasma and Its Safety Analysis.
常压等离子体放射性废物净化工艺开发及其安全性分析。
  • 批准号:
    13558060
  • 财政年份:
    2001
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)

相似海外基金

Defining the anti-fibrotic mechanisms of prostacyclin drugs in pulmonary fibrosis
定义前列环素药物在肺纤维化中的抗纤维化机制
  • 批准号:
    MR/X001814/1
  • 财政年份:
    2023
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Fellowship
Analysis on the function of prostacyclin synthase expressed in macrophages in inflammatory diseases
巨噬细胞表达的前列环素合酶在炎症性疾病中的功能分析
  • 批准号:
    22K15283
  • 财政年份:
    2022
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the pathogenesis of renal angiopathy due to prostacyclin deficiency and approaches to improvement and prevention
阐明前列环素缺乏性肾血管病的发病机制及改善和预防方法
  • 批准号:
    17K00890
  • 财政年份:
    2017
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Sustained-release delivery of prostacyclin analogue(ONO-1301) enhances lung regeneration after pnuemonectomy in mice
缓释前列环素类似物(ONO-1301)可增强小鼠肺切除术后的肺再生
  • 批准号:
    15K10255
  • 财政年份:
    2015
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The pathologic clarification and new therapy development for glaucoma derived from prostacyclin receptor abnormality
前列环素受体异常所致青光眼的病理阐明及新疗法开发
  • 批准号:
    15K15639
  • 财政年份:
    2015
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Novel biodegradable drug polymers to realise the therapeutic potential of prostacyclin drugs
新型可生物降解药物聚合物实现前列环素药物的治疗潜力
  • 批准号:
    BB/L015803/1
  • 财政年份:
    2014
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Training Grant
Target-Oriented Synthesis of the Prostacyclin Derivative Beraprost
前列环素衍生物贝前列素的靶向合成
  • 批准号:
    239898471
  • 财政年份:
    2013
  • 资助金额:
    $ 7.87万
  • 项目类别:
    Research Fellowships
The Wnt and Prostacyclin pathways act in concert to inhibit NSCLC cell growth
Wnt 和前列环素途径协同作用抑制 NSCLC 细胞生长
  • 批准号:
    8398949
  • 财政年份:
    2011
  • 资助金额:
    $ 7.87万
  • 项目类别:
Common targeting of the prostacyclin-PPARy axis in COPD and lung cancer
COPD 和肺癌中前列环素-PPARy 轴的共同靶向
  • 批准号:
    8320228
  • 财政年份:
    2011
  • 资助金额:
    $ 7.87万
  • 项目类别:
The Wnt and Prostacyclin pathways act in concert to inhibit NSCLC cell growth
Wnt 和前列环素途径协同作用抑制 NSCLC 细胞生长
  • 批准号:
    8047429
  • 财政年份:
    2011
  • 资助金额:
    $ 7.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了